bf/NASDAQ:ARCT_icon.jpeg

COM:ARCTURUSRX

Arcturus Therapeutics

  • Stock

Last Close

18.33

07/11 21:00

Market Cap

585.23M

Beta: -

Volume Today

316.30K

Avg: -

Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in ...Show More

peer of

competitor of